Biotech Firm Tevogen Bio Cleared for New Stock Offering as SEC Approves Registration

Rhea-AI Filing Summary

The SEC has declared Tevogen Bio Holdings' Form S-3 registration statement effective as of June 26, 2025, at 4:30 P.M. This Form S-3 filing (File Number: 333-288218) represents a shelf registration statement that allows the company to offer and sell securities to the public.

Form S-3 is a simplified security registration form used by companies that have met certain reporting requirements and have a minimum public float. This effectiveness notice indicates that:

• Tevogen Bio Holdings can now proceed with its planned securities offering
• The company has satisfied SEC registration requirements
• The registration statement has been reviewed and approved by the SEC

This development is significant for investors as it enables Tevogen Bio Holdings to access the capital markets more efficiently, potentially leading to future securities offerings under this shelf registration.

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	June 26, 2025 4:30 P.M.

Form:

S-3

CIK:	0001860871
Company Name:	Tevogen Bio Holdings Inc.
File Number:	333-288218

FAQ

When did TVGNW's S-3 registration statement become effective?

TVGNW's S-3 registration statement became effective on June 26, 2025 at 4:30 P.M. as indicated in the SEC Notice of Effectiveness.

What is the file number for TVGNW's S-3 registration?

The file number for TVGNW's (Tevogen Bio Holdings Inc.) S-3 registration is 333-288218.

What is TVGNW's CIK number with the SEC?

TVGNW's (Tevogen Bio Holdings Inc.) CIK number with the SEC is 0001860871.

When did TVGNW file their Notice of Effectiveness with the SEC?

TVGNW filed their Notice of Effectiveness with the SEC on June 28, 2025, while the effectiveness date itself was June 26, 2025.